COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says

• Published in: Frontiers in immunology Vol. 12; p. 669010
• Main Authors: Chen, Gang, Li, Xiaolin, Sun, Meixing, Zhou, Yangzhong, Yin, Meifang, Zhao, Bin, Li, Xuemei
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 21.05.2021
• Subjects: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; adverse event; Aged; COVID-19; COVID-19 - prevention & control; COVID-19 Vaccines - adverse effects; Female; Humans; Immunology; Male; Middle Aged; mRNA; mRNA Vaccines; safety issue; SARS-CoV-2; United States; Vaccination - adverse effects; vaccine; Vaccines, Synthetic - adverse effects; Young Adult; United States; COVID-19; safety issue; adverse event; vaccine; mRNA

The prophylactic vaccination of COVID-19 mRNA vaccines is the first large-scale application of this kind in the human world. Over 1.8 million doses of the COVID-19 vaccine had been administered in the US until December 2020, and around 0.2% submitted AE reports to the Vaccine Adverse Event Reporting...